PATENT CLAIM ANALYSIS

Application Number: 15990542
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["435", "091100"]

Abstract:
Provided herein are compositions and methods for the treatment of retinal diseases. The compositions and methods include a therapeutic agent conjugated to a vitreous component binding moiety. The vitreous component binding moiety may be an aptamer or a small molecule that binds to a structural component of the vitreous humor (e.g., hyaluronic acid, collagen or vitronectin).

Claim (Index 9):
The composition of  claim 1 , wherein said composition has an intravitreal half-life of at least 6 days in a human, an intravitreal half-life of at least 2 days in a rabbit, an intravitreal half-life of at least 3 days in a non-human primate, or any combination thereof.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 93.0
- Lexical Diversity: 1.46512
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10926806', '14768701', '15274612', '12465051', '15639573']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5927756602656311
- 35 USC 102 Novelty (BERT): 0.5136570236933605
- Combined Prediction Score: 0.584863796608404
- Mean Citation Score: 239.18448000000004
- Max Citation Score: 243.5884
- Similarity Product: 136.562288018322

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test